AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for BSX is Avoid ↓; the stock is at $52.15 (+0.88% today); overbought (RSI 73); technical trend is down-trend; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $52.15 |
| Change today | +0.88% |
| RSI (14) | 72.98 |
| Relative volume | 0.63 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $75.6B |
| Forward P/E | 15.22 |
| 52-week high | -52.5% away |
| 52-week low | +23.3% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Nan |
| Sector | Healthcare-Devices |
| Next earnings | 7/29/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns BSX (Boston Scientific Corp) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
BSX's RSI is overbought (RSI 73). A reading above 70 is typically considered overbought and below 30 oversold.
BSX is trading about 52% below its 52-week high and 23% above its 52-week low as of Aug 14 2026, 1:04 PM.
BSX's next earnings date is 7/29/2026 8:30:00 AM.
BSX is classified under Healthcare-Devices in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.